Armstrong, MD, MPH, chief of dermatology, UCLA, discusses clinical trial findings from the phase 2b study on zasocitinib.

Co. Ltd. has divulged non-receptor tyrosine-protein kinase TYK2 inhibitors reported to be useful for the treatment of psoriasis, psoriatic arthritis, ulcerative colitis, Crohn’s disease and systemic ...

Alumis, a recent IPO, has ESK-001, a promising phase 3 TYK2 inhibitor for Psoriasis and SLE, showing superior efficacy and safety over existing treatments. ESK-001's allosteric inhibition offers high ...

Cambridge-based biotechnology firm Sareum Holdings announced on Monday that it has received a notice of allowance from the ...

(Alliance News) - Sareum Holdings PLC on Monday announced it has received a patent allowance for the development of crystalline forms of SDC-1801 in China.

Immunology and Inflammation Virtual Summit Wednesday, September 18, 2024, 10:00 am ET Format: presentation About Alumis Alumis is a clinical-stage biopharmaceutical company developing oral therapies ...

You can use many eczema treatments while pregnant, including: Skin care, including applying moisturizer to help repair your skin. For more tips, go to Eczema types: Atopic dermatitis skin care.

VTAMA cream is a novel, non-steroidal topical therapy approved for treatment of plaque psoriasis in adults and is under FDA review for an ...

Kymera Therapeutics (KYMR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

We are excited to initiate this trial of VTX3232 in patients with early Parkinson’s disease,” said Mark Forman, MD, PhD, Chief Medical Officer. “There is a compelling body of evidence from the ...

In addition to VTAMA, Roivant's pipeline includes IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting the neonatal Fc receptor ("FcRn") in development across several IgG-mediated ...